Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waid-Verarbeitungs-GmbH is a specialized German company dedicated to the cultivation and industrial processing of woad (Isatis tinctoria), a plant with a long history in both the dye and medicinal industries. Based in Pferdingsleben, Thuringia, the company produces high-quality botanical extracts and oils that are utilized as active ingredients in the pharmaceutical and cosmetic sectors. Their products are particularly noted for their anti-inflammatory and antimicrobial properties, making them effective in treating chronic skin conditions such as neurodermatitis and psoriasis. By managing the entire value chain from agricultural production to refined extraction, the company ensures the delivery of standardized, high-purity natural products. Waid-Verarbeitungs-GmbH collaborates with research institutions to further explore the therapeutic potential of woad-derived compounds in modern dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waid Verarbeitungs.